MariMed Stock Forecast for 2023 - 2025 - 2030

Updated on 05/02/2024

Stock Rating
10
Price Target
$0.50
Consensus
Outperform
Upside
66.67%
Analysts
1
Stock Rating
10
Upside
66.67%
Analysts
1
Price Target
$0.50

MariMed Stock Forecast and Price Target

MariMed has an average price target of $0.50 recently offered by notable experts for 2024, which would represent a potential upside of approximately 66.67% from the last closing price in May, 2024 if reached. This potential increase is based on a high estimate of $0.50 and a low estimate of $0.50. If you are interested in MRMD stock, you should also look at its competitors.

$0.50

66.67% Upside

Outperform
Outperform

MariMed Fair Value Forecast for 2023 - 2025 - 2030

In the last two years, MariMed's Price has fallen from $0.90 to $0.00 – a 100.00% decrease. For next year, analysts predict Fair Value of $0.32, which would mean an increase of 100.00%. Over the next seven years, experts predict that MariMed's Fair Value will grow at a rate of 100.00%.

2024 Fair Value Forecast
$0.32
2025 Fair Value Forecast
$0.36
2026 Fair Value Forecast
$0.40
2027 Fair Value Forecast
$0.44
2028 Fair Value Forecast
$0.49
2029 Fair Value Forecast
$0.55
2030 Fair Value Forecast
$0.61

MariMed Revenue Forecast for 2023 - 2025 - 2030

In the last three years, MariMed's Revenue has grown by 191.94%, rising from $50.90M to $148.60M. For next year, analysts predict Revenue of $172.90M, which would mean an increase of 16.35%. Over the next seven years, experts predict that MariMed's Revenue will grow at a rate of 14.91%.

2024 Rev Forecast
$0.17B
2025 Rev Forecast
$0.19B
2026 Rev Forecast
$0.17B
2027 Rev Forecast
$0.16B
2028 Rev Forecast
$0.17B
2029 Rev Forecast
$0.17B
2030 Rev Forecast
$0.17B

MariMed Dividend per Share Forecast for 2023 - 2025 - 2030

MariMed Free Cash Flow Forecast for 2023 - 2025 - 2030

2024 FCF Forecast
$0.00B
2025 FCF Forecast
$0.02B
2026 FCF Forecast
$0.00B
2027 FCF Forecast
$0.01B
2028 FCF Forecast
$0.03B
2029 FCF Forecast
$0.08B
2030 FCF Forecast
$0.03B

MariMed EBITDA Forecast for 2023 - 2025 - 2030

MariMed's EBITDA has grown In the last three years, rising from $16.71M to $23.65M – a growth of 41.53%. In the next year, analysts believe that EBITDA will reach $36.60M – an increase of 54.76%. For the next seven years, experts predict that MariMed's EBITDA will grow at a rate of 72.29%.

2024 EBITDA Forecast
$0.04B
2025 EBITDA Forecast
$0.05B
2026 EBITDA Forecast
$0.04B
2027 EBITDA Forecast
$0.04B
2028 EBITDA Forecast
$0.04B
2029 EBITDA Forecast
$0.04B
2030 EBITDA Forecast
$0.04B

MariMed EBIT Forecast for 2023 - 2025 - 2030

MariMed's EBIT has seen impressive growth In the last three years, rising from $14.53M to $15.08M – a growth of 3.79%. In the next year, analysts believe that EBIT will reach $16.16M – an increase of 7.16%. For the next seven years, the forecast is for EBIT to grow by 26.91%.

2024 EBIT Forecast
$0.02B
2025 EBIT Forecast
$0.02B
2026 EBIT Forecast
$0.02B
2027 EBIT Forecast
$0.02B
2028 EBIT Forecast
$0.02B
2029 EBIT Forecast
$0.02B
2030 EBIT Forecast
$0.02B

MariMed EPS Price Prediction Forecast for 2023 - 2025 - 2030

In the last two years, MariMed's EPS has fallen from $0.06 to $0.00 – a 100.00% decrease. For next year, analysts predict EPS of $-0.01, which would mean an increase of 100.00%. Over the next seven years, experts predict that MariMed's EPS will grow at a rate of 100.00%.

2024 EPS Forecast
$-0.01
2025 EPS Forecast
$0.02
2026 EPS Forecast
$0.01
2027 EPS Forecast
$0.01
2028 EPS Forecast
$0.01
2029 EPS Forecast
$0.01
2030 EPS Forecast
$0.01